TORRENT PHARMACEUTICALS L revenue breakdown overview

TORRENT PHARMACEUTICALS L revenue for the last year amounted to 107.28 B INR, the most of which — 107.28 B INR — came from its highest performing source at the moment, Generic Formulation, the year earlier bringing 96.20 B INR. The greatest contribution to the revenue figure was made by India — last year it brought TORRENT PHARMACEUTICALS L 61.09 B INR, and the year before that — 53.70 B INR.